• Home
  • A-B index
  • Pharmacological Index
  • Drug Classes
  • Active Ingredients
  • Companies
  • News
  • Desmopressin Teva
    / Teva


    Active Ingredient
    Desmopressin Acetate 0.1 mg, 0.2 mg

    Status in Israel
    RX

    Presentation and Status in Health Basket

    Presentation Basket Yarpa Pharmasoft

    Tablets

    30 X 0.1 mg

    not in the basket chart 30583 4551

    Tablets

    30 X 0.2 mg

    not in the basket chart 30593 4552

    Related information


    Dosage

    See prescribing information for full details.


    Indications

    Indicated for central diabetes insipidus, nocturnal enuresis (in patients from 5 years of age with normal ability to concentrate the urine) and for symptomatic treatment of nocturia in adults associated with nocturnal polyuria, i.e. nocturnal urine production exceeding bladder capacity. The treatment must be started before the age of 65.


    Contra-Indications

    Habitual or psychogenic polydipsia (resulting in a urine production exceeding 40 ml/kg/24 hours). Syndrome of inappropriate ADH secretion (SIADH). Known hyponatremia. History of known or suspected cardiac insufficiency and other conditions requiring treatment with diuretics. Moderate and severe renal insufficiency (creatinine clearance below 50 ml/min). Hypersensitivity to desmopressin or to any of the excipients.


    Special Precautions

    Please contact distributing company for full details.


    Side Effects

    Please contact distributing company for full details.


    Drug interactions

    Please contact distributing company for full details.


    Manufacturer
    Teva Hungary
    CLOSE